Cross-reactive Immunity Against the SARS-CoV-2 Omicron Variant is Low in Pediatric Patients with Prior COVID-19 or MIS-C.
Nature Communications(2022)
Key words
Antibodies,SARS-CoV-2,Vaccines,Viral infection,Science,Humanities and Social Sciences,multidisciplinary
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined